Image shows six devices with biosensors to detect whether a cancer cell is...
Image shows six devices with biosensors to detect whether a cancer cell is alive when it passes through a tiny hole for fluids. The devices fit on a 3-inch wide piece of glass.
Source: Zhongtian Lin

Device tests if targeted chemotherapy is working

Rutgers researchers have created a device that can determine whether targeted chemotherapy drugs are working on individual cancer patients. The portable device, which uses artificial intelligence and biosensors, is up to 95.9 percent accurate in counting live cancer cells when they pass through electrodes.

“We built a portable platform that can predict whether patients will respond positively to targeted cancer therapy,” said senior author Mehdi Javanmard, an assistant professor in the Department of Electrical and Computer Engineering in the School of Engineering at Rutgers University–New Brunswick. “Our technology combines artificial intelligence and sophisticated biosensors that handle tiny amounts of fluids to see if cancer cells are sensitive or resistant to chemotherapy drugs.”

The device provides immediate results and will allow for more personalized interventions for patients as well as better management and detection of the disease. It can rapidly analyze cells without having to stain them, allowing for further molecular analysis and instantaneous results. Current devices rely on staining, limiting the characterization of cells. “We envision using this new device as a point-­of-­care diagnostic tool for assessing patient response and personalization of therapeutics,” the study says.

Treatment of cancer patients often requires drugs that can kill tumor cells, but chemotherapy destroys both tumor cells and healthy cells, causing side effects such as hair loss and gastrointestinal problems.

Co-author Joseph R. Bertino, a resident researcher at Rutgers Cancer Institute of New Jersey and professor at Rutgers Robert Wood Johnson Medical School, and his team previously developed a therapeutic approach that targets cancer cells, such as those in B­-cell lymphoma, multiple myeloma and epithelial carcinomas. It binds a chemotherapy drug to an antibody so only tumor cells are targeted, and minimizes interaction with healthy cells. Patients will respond positively to this therapy if their tumor cells generate a protein called matriptase. Many patients will benefit while the side effects from standard chemotherapy are minimized. “Novel technologies like this can really have a positive impact on the standard-of-care and result in cost-savings for both healthcare providers and patients,” Bertino said.

The Rutgers team tested their new device using cancer cell samples treated with different concentrations of a targeted anti­cancer drug. The device detects whether a cell is alive based on the shift in its electrical properties as it passes through a tiny fluidic hole. The next step is to perform tests on tumor samples from patients. The researchers hope the device will eventually be used to test cancer therapies on samples of patient tumors before treatment is administered.

Subscribe to our newsletter

Related articles

Smart biosensor to explore the biomolecular world

Smart biosensor to explore the biomolecular world

Scientists have developed AI-powered nanosensors that let researchers track various kinds of biological molecules without disturbing them.

A paper-based living device for detecting biological signals

A paper-based living device for detecting biological signals

Researchers have designed a cellular device capable of detecting and processing biological signals outside the laboratory.

AI method can detect precursors to cervical cancer

AI method can detect precursors to cervical cancer

Using AI and mobile digital microscopy, researchers hope to create screening tools that can detect precursors to cervical cancer in women in resource-limited settings.

Diagnosing prostate cancer using biosensors and AI

Diagnosing prostate cancer using biosensors and AI

Successful precision cancer diagnosis through an AI analysis of multiple factors of prostate cancer. Potential application of the precise diagnoses of other cancers by utilizing a urine test.

AI finds patterns of mutations in tumour images

AI finds patterns of mutations in tumour images

Researchers have developed an AI algorithm that uses computer vision to analyze tissue samples from cancer patients.

The next-gen 'smart pill' for cancer detection

The next-gen 'smart pill' for cancer detection

Researchers are developing a pill-sized capsule that uses AI-enabled sensing to diagnose gastrointestinal cancers and bleeding earlier.

Scientists model heart attack on a chip

Scientists model heart attack on a chip

The chip is capable of precisely controlling oxygen and nutrient levels, and allowing observation of cell behavior in real time.

Lab-on-a-chip detects cancer less invasively

Lab-on-a-chip detects cancer less invasively

A new ultrasensitive diagnostic device could allow doctors to detect cancer quickly from a droplet of blood or plasma, leading to timelier interventions and better outcomes for patients.

Medical needles for high-tech cancer diagnostics

Medical needles for high-tech cancer diagnostics

Modern medicine needs better quality samples than traditional biopsy needles can provide, ultrasonically oscillating needles can improve treatment and reduce discomfort.

Popular articles

Subscribe to Newsletter